Exploiting tumour hypoxia in cancer treatment.
Brown
J Martin
JM
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford, California 94305, USA. mbrown@stanford.edu
Wilson
William R
WR
D001421:Bacteria, Anaerobic / Q000502:physiology; D015687:Cell Hypoxia; D004268:DNA-Binding Proteins / Q000494:pharmacology / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D015316:Genetic Therapy; D018257:Helix-Loop-Helix Motifs; D006801:Humans; D051793:Hypoxia-Inducible Factor 1; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D009336:Necrosis; D009369:Neoplasms / Q000503:physiopathology* / Q000628:therapy*; D009687:Nuclear Proteins / Q000494:pharmacology / Q000627:therapeutic use*; D011355:Prodrugs; D014157:Transcription Factors
D004268:DNA-Binding Proteins; C497442:HIF1A protein, human; D051793:Hypoxia-Inducible Factor 1; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D009687:Nuclear Proteins; D011355:Prodrugs; D014157:Transcription Factors